Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study. [electronic resource]
Producer: 20171107Description: 755-65 p. digitalISSN:- 1463-1326
- Adult
- Angina, Unstable -- epidemiology
- Cardiovascular Diseases -- epidemiology
- Cohort Studies
- Databases, Factual
- Diabetes Mellitus, Type 2 -- drug therapy
- Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin -- metabolism
- Hospitalization -- statistics & numerical data
- Humans
- Hypoglycemic Agents -- therapeutic use
- Incretins -- therapeutic use
- Insulin -- therapeutic use
- Male
- Metformin -- therapeutic use
- Middle Aged
- Myocardial Infarction -- epidemiology
- Myocardial Revascularization -- statistics & numerical data
- Propensity Score
- Proportional Hazards Models
- Retrospective Studies
- Stroke -- epidemiology
- Sulfonylurea Compounds -- therapeutic use
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.